A SARS-CoV-2 Vaccine Designed for Manufacturability Results in Unexpected Potency and Non-Waning Humoral Response

Ireland News News

A SARS-CoV-2 Vaccine Designed for Manufacturability Results in Unexpected Potency and Non-Waning Humoral Response
Ireland Latest News,Ireland Headlines
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

Novel Rutgers COVID vaccine may provide long-lasting protection RutgersU

Vero E6 cells were propagated in DMEM containing L-glutamine and 10% FBS to 80% confluency in multiple T75 flasks , and harvested by gentle dissociation of the monolayer with Accutase Cell Detachment Solution following the instructions of the manufacturer . Pooled cells were washed twice in sterile PBS and checked for viability by the Trypan Blue exclusion method.

At 18 h post-seeding, the cells were washed with sterile PBS , and 400 µL of 10-fold dilutions of the virus inoculum, prepared in serum-free DMEM, was added to each well and incubated at 37 °C with gentle rocking of plates every 15 min for 1 h. Then, the virus inoculum was carefully removed, and the infected cells were overlayed with 4 mL/well of 1.6% agarose prepared in DMEM with 4% FBS.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

Ireland Latest News, Ireland Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Omicron's grip on Sweden: High transmission rates persist despite high seroprevalenceOmicron's grip on Sweden: High transmission rates persist despite high seroprevalenceResearch paper reports on a study conducted in Sweden to determine the prevalence of SARS-CoV-2 Omicron infection despite high seroprevalence. The study found a high prevalence of SARS-CoV-2 Omicron infection in Sweden despite high seroprevalence.
Read more »

The safety and efficacy of FINLAY-FR-2/1A, a new protein-based COVID-19 vaccineThe safety and efficacy of FINLAY-FR-2/1A, a new protein-based COVID-19 vaccineThe safety and efficacy of FINLAY-FR-2/1A, a new protein-based COVID-19 vaccine FINLAYFR2 Soberana02 FINLAYFR1A SoberanaPlus COVID19 Phase3trial clinicaltrial vaccination immunization publichealth pandemic JAMANetworkOpen
Read more »

Maine CDC Identifies Positive Measles Test in a ChildMaine CDC Identifies Positive Measles Test in a ChildThe Maine Center for Disease Control and Prevention says it has received a report of a positive measles test in a Maine child and is awaiting information from the U.S. Centers for Disease Control and Prevention. The child did get the measles vaccine, but the Maine CDC said it is not possible to contract measles from the vaccine. The agency…
Read more »

Omicron's grip on Sweden: High transmission rates persist despite high seroprevalenceOmicron's grip on Sweden: High transmission rates persist despite high seroprevalenceResearch paper reports on a study conducted in Sweden to determine the prevalence of SARS-CoV-2 Omicron infection despite high seroprevalence. The study found a high prevalence of SARS-CoV-2 Omicron infection in Sweden despite high seroprevalence.
Read more »

Creating King's anointing screen was an honour, says designerCreating King's anointing screen was an honour, says designerIconographer Aidan Hart designed the screen that shielded King Charles III during the Coronation.
Read more »

The outfits Kate, Camilla and other royals wore to the coronationThe outfits Kate, Camilla and other royals wore to the coronationKate's dress is designed by Alexander McQueen, while Camilla is wearing a Bruce Oldfield gown.
Read more »



Render Time: 2025-04-12 04:39:25